 - With histologically or cytologically confirmed recurrent or refractory unresectable Stage IV gastric or gastro-esophageal junctional adenocarcinoma according to American Joint Committee on CancerUnion Internationale Contre le Cancer UICC 7th edition and whose disease progressed after one or two prior chemotherapy regimens involving both fluoropyrimidines and platinum 